Status: Not yet recruiting
A Long-Term Follow-Up Trial for Participants Enrolled in CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) Trials
This is an open label, multi-center, long-term safety and efficacy follow-up trial for participants who have been treated with Senza5 CART5.
Participants needed: 30
Trial details
Age: 18-100Biological sex: AllType: ObservationalSponsor: Vittoria BiotherapeuticsUpdated: Jul 30, 2026
Eligibility criteria
Provision of written informed consent by the participant or provision of written... [+2]
There are no exclusion criteria.